{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:01:01Z","timestamp":1792735261407,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.autrev.2015.01.018","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T01:45:49Z","timestamp":1423014349000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Fecal calprotectin in systemic sclerosis and review of the literature"],"prefix":"10.1016","volume":"14","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Leroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Quillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ducrotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.01.018_bb0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.autrev.2014.03.003","article-title":"Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene?","volume":"13","author":"Bernal-Bello","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.autrev.2014.12.001","article-title":"Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis","volume":"14","author":"Chora","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","article-title":"Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy","volume":"12","author":"Cipriani","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2013.09.006","article-title":"Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature","volume":"13","author":"Colaci","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.autrev.2013.05.002","article-title":"Systemic sclerosis at the crossroad of polyautoimmunity","volume":"12","author":"Elhai","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0040","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","article-title":"Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature","volume":"12","author":"Giuggioli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.autrev.2013.04.004","article-title":"Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sj\u00f6gren's syndrome","volume":"12","author":"Jimenez","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.11.006","article-title":"The role of nail-videocapillaroscopy in early diagnosis of scleroderma","volume":"12","author":"Rossi","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2014.10.009","article-title":"A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients","volume":"14","author":"Silva","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2014.11.002","article-title":"Undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc)","volume":"14","author":"Valentini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0080","doi-asserted-by":"crossref","first-page":"iii36","DOI":"10.1093\/rheumatology\/ken485","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.01.018_bb0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/apt.12818","article-title":"Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis","volume":"40","author":"Marie","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2015.01.018_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2015.01.018_bb0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.01.018_bb0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1365-2036.2006.03180.x","article-title":"Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy","volume":"24","author":"Marie","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2015.01.018_bb0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/rheumatology\/kel203","article-title":"Outcome of small bowel motor impairment in systemic sclerosis: a prospective manometric 5-year follow-up","volume":"46","author":"Marie","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.01.018_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0115","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/art.34374","article-title":"Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis","volume":"64","author":"Marie","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.01.018_bb0120","first-page":"1874","article-title":"Gastric involvement in systemic sclerosis: a prospective study","volume":"41","author":"Marie","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0125","first-page":"77","article-title":"Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study","volume":"96","author":"Marie","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.01.018_bb0130","first-page":"30","article-title":"Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases","volume":"58","author":"Poirier","year":"1972","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0135","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.01.018_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autrev.2013.06.006","article-title":"Rheumatic manifestations in inflammatory bowel disease","volume":"13","author":"Atzeni","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.autrev.2014.10.004","article-title":"The mechanisms behind helminth's immunomodulation in autoimmunity","volume":"14","author":"Bashi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","article-title":"Optimizing anti-TNF treatments in inflammatory bowel disease","volume":"13","author":"Ben-Horin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.autrev.2014.11.004","article-title":"Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes","volume":"14","author":"Bonneau","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2013.06.007","article-title":"Immunity, autoimmunity and inflammatory bowel disease","volume":"13","author":"Cassinotti","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.autrev.2014.02.004","article-title":"The use of biosimilars in immune-mediated disease: a joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn's disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0190","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2015.01.018_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2013.09.011","article-title":"New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease","volume":"13","author":"Lin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.autrev.2014.10.013","article-title":"The intestinal microbiota and microenvironment in liver","volume":"14","author":"Ma","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0205","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/j.crohns.2013.06.008","article-title":"GETAID (Groupe d'\u00c9tude Th\u00e9rapeutique Des Affections Inflammatoires Digestives). Serum calprotectin as a biomarker for Crohn's disease","volume":"7","author":"Meuwis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2015.01.018_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.autrev.2013.06.003","article-title":"Targets for new immunomodulation strategies in inflammatory bowel disease","volume":"13","author":"Monteleone","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0215","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.autrev.2012.04.006","article-title":"Intravenous immunoglobulin for the treatment of Crohn's disease","volume":"12","author":"Rogosnitzky","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.018_bb0225","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar4475","article-title":"Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sj\u00f6gren's syndrome and rheumatoid arthritis","volume":"16","author":"Andr\u00e9asson","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.01.018_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2010.02340.x","article-title":"Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis","volume":"270","author":"Andr\u00e9asson","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2015.01.018_bb0235","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.01.018_bb0240","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Leroy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2015.01.018_bb0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2008.05.008","article-title":"Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease","volume":"41","author":"Gisbert","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2015.01.018_bb0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0b013e3282f1c9a7","article-title":"Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis","volume":"20","author":"Johnson","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0260","first-page":"1569","article-title":"Role of fecal calprotectin in gastrointestinal disorders","volume":"17","author":"Montalto","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2015.01.018_bb0265","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ibd.21136","article-title":"Fecal calprotectin variability in Crohn's disease","volume":"16","author":"Moum","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2015.01.018_bb0270","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","article-title":"S100A8 and S100A9 in inflammation and cancer","volume":"72","author":"Gebhardt","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0275","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2015.01.018_bb0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0285","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/j.1572-0241.2003.07630.x","article-title":"Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia","volume":"98","author":"Limburg","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0290","doi-asserted-by":"crossref","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.01.018_bb0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MPG.0b013e318262a718","article-title":"Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children","volume":"55","author":"Chen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2015.01.018_bb0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/2050640614546947","article-title":"Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: an observational study from Southern India","volume":"2","author":"Larsson","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.autrev.2015.01.018_bb0305","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/00365521.2013.775329","article-title":"Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni\/coli gastroenteritis","volume":"48","author":"Nielsen","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2015.01.018_bb0310","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.61.8.754","article-title":"Ultrastructural study of the muscle coat of the gastric wall in a case of systemic sclerosis","volume":"61","author":"Ibba-Manneschi","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.01.018_bb0315","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/art.23806","article-title":"Endothelial\/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis","volume":"58","author":"Manetti","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.01.018_bb0320","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gut.2005.086074","article-title":"A case\u2013control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)","volume":"55","author":"Roberts","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2015.01.018_bb0325","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/ar4106","article-title":"Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study","volume":"14","author":"Matzkies","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"14","key":"10.1016\/j.autrev.2015.01.018_bb0330","first-page":"925","article-title":"Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission","volume":"S1542\u20133565","author":"Guardiola","year":"2014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T13:51:49Z","timestamp":1537883509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1568997215000336"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.01.018","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal calprotectin in systemic sclerosis and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}